Qure.ai’s AI-backed solution interprets X-rays to help doctors classify patients as high-, medium- or low-risk and prioritise testing accordingly
Related News
News
28 Feb 2023
Qure.ai and Therapixel announce partnership to improve access...
Read more
News
22 Feb 2023
Qure.ai Awarded EU MDR Certification for Its AI...
Read more
News
31 Jan 2023
Qure.ai validated on Fujifilm’s AI-enabled platform REiLI®
Read more
News
25 Nov 2022
Qure.ai Appoints Darren Stephens as Head of European...
Read more
News
28 Sep 2022
Qure.ai appoints Dr. Shibu Vijayan as Medical Director...
Read more
News
06 Sep 2022
Qure.ai and Erasmus MC Launch AI Innovation Centre...
Read more
News
09 Aug 2022
Fujifilm and Qure.ai join hands with IHVN to...
Read more
News
28 Jul 2022
Qure.ai adds Impact Investor TEAMFund LP to its...
Read more
News
14 Jul 2022
Centre for Infectious Disease Research in Zambia (CIDRZ)...
Read more
News
13 Jul 2022
Unilabs signs on Qure.ai for triaging chest X-rays
Read more
News
06 May 2022
Qure.ai Announces Appointment of Amit Kakar and Charles-Antoine...
Read more
News
20 Apr 2022
USAID-supported SAMRIDH Healthcare Blended Finance Facility supports Qure.ai...
Read more
